This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Sun May 19, 2013 1:58 pm

View unanswered posts | View active topics


Board index » Treatments » Chronic Cerebrospinal Venous Insufficiency (CCSVI)

All times are UTC - 8 hours [ DST ]



Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 
  Print view Previous topic | Next topic 
Author Message
Cece
PostPosted: Wed Oct 03, 2012 8:27 am 
Offline
Family Elder

Joined: Mon Jan 04, 2010 4:00 pm
Posts: 8505
http://www.medpagetoday.com/clinical-co ... id=5517461
Quote:
Retinal thickness as measured with a high-tech ocular scanner in multiple sclerosis (MS) patients correlated significantly with the volumes of certain brain structures, researchers said.
Quote:
Overall, Saidha and colleagues concluded, "although our observations require verification, they provide support for the potential use of OCT [optical coherence tomography] as an adjunctive outcome measure in MS clinical trials."

If OCT is able to substitute as a measurement of brain atrophy, then it may well be a measurement that responds to CCSVI treatment. I don't think it's very expensive either. There have been anecdotal reports, mainly by Cheer, of improvement in brain atrophy after CCSVI treatment, and it's logical to think that if the improved blood flow is positive in many ways for brain health, that this will have an impact on atrophy.
Quote:
Associations between retinal thickness measurements and brain substructure volumes were different for MS patients' eyes versus eyes without a history of optic neuritis.

Almost none of the correlations were significant in the optic neuritis eyes, whereas one or more retinal thickness measurements were significantly (P<0.05) correlated with volumes of cortical gray matter, normal-appearing white matter, caudate, thalamus, and MS-type lesions.

Huh. A trial of CCSVI using OCT as an outcome measurement would have to exclude eyes with a history of optic neuritis.
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 

Board index » Treatments » Chronic Cerebrospinal Venous Insufficiency (CCSVI)

All times are UTC - 8 hours [ DST ]

Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. objective measurement of fatigue

Cece

1

240

Fri Nov 30, 2012 4:23 pm

munchkin View the latest post

There are no new unread posts for this topic. measurement of azygous blood flow

Cece

5

827

Thu Jul 21, 2011 4:20 pm

Johnson View the latest post

There are no new unread posts for this topic. Non-invasive measurement of Azygous vein bloodflow...

ikulo

2

1174

Mon May 17, 2010 11:47 am

hwebb View the latest post

There are no new unread posts for this topic. Clinical Trials for CCSVI and MS

MarkW

3

1284

Thu Dec 24, 2009 4:44 am

MarkW View the latest post

There are no new unread posts for this topic. NHS Trials for CCSVI in the UK Rejected

[ Go to pageGo to page: 1, 2 ]

ConstableComfortable

16

2215

Sat Jan 29, 2011 9:54 am

Cece View the latest post

 


Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: